Episode Details

Johnson & Johnson is pouring $5.5 billion into settling tens of thousands of lawsuits claiming their talc-based baby powder caused ovarian cancer, with $3 billion due by 2027 and the rest by 2028 — a move they frame as closing a 15-year chapter of what they call baseless litigation. Despite decades of denial and scientific debate over whether talc links to cancer, the company pulled its talc powder from North America in 2020 and globally in 2023, switching to cornstarch. A federal judge recently questioned the validity of nearly 70,000 claims, demanding proof of direct causation. While J&J’s legal team insists the lawsuits lack scientific merit and they’d have won in court, plaintiff lawyers see the settlement as a long-overdue, if delayed, form of justice.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/c1d5cf351a400ff4